MissionIR Articles
Original content written and distributed as part of our ongoing relationships.
-
AI Drones Dropping Mines As Minefields Return to Europe, Safe Pro Group Inc. (NASDAQ: SPAI) Delivers Scalable AI Drone Tech to Detect the Old and New Threat
The Cold War-era threat of land mines is resurfacing in Europe with a new layer, dropping mines from AI Drones. According to a recent New York Times report, five NATO-aligned countries – Poland, Finland, and the three…
-
MissionIRNewsBreaks – Rare Biotech Story: Nutriband Inc. (NASDAQ: NTRB) Featured on Smart Money Podcast
Nutriband (NASDAQ: NTRB) was recently featured on the Smart Money Circle Show, where Serguei Melnik, NTRB’s founder and president, unveiled his no-nonsense approach to biotech entrepreneurship. Standing in stark contrast to the conventional playbook are his grounded…
-
SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Clears Regulatory Hurdle for 7.2 MW Hoadley Hill Solar Project in New York
Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and…
-
BluSky AI Inc. (BSAI): Building the Infrastructure Behind the Intelligence
As generative AI sweeps across industries, from healthcare to marketing to national defense, one major problem threatens to stall progress: infrastructure. The computer power required to support artificial intelligence is exponentially higher than traditional internet…
-
MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Targets Multiple 2025–2026 Catalysts Across Rare Disease Pipeline
Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company developing therapies for rare diseases with unmet medical needs, issued a shareholder update outlining key clinical and strategic milestones. President and CEO Dr. Christopher J. Schaber highlighted upcoming…
-
Safe Pro Group Inc. (NASDAQ: SPAI) Is ‘One to Watch’
Safe Pro Group (NASDAQ: SPAI) is a mission-driven technology company delivering advanced AI-powered security and defense solutions. It is focused on serving customers in the defense, homeland security, humanitarian, law enforcement, and commercial markets where its AI,…
-
MissionIRNewsBreaks – Why HeartBeam Inc. (NASDAQ: BEAT) Is ‘One to Watch’
HeartBeam (NASDAQ: BEAT) is a medical technology company developing a groundbreaking solution for at-home detection and monitoring of cardiac conditions. “HeartBeam’s vision is to redefine cardiac care by enabling early detection, proactive monitoring, and informed clinical…
-
Safe Pro Group Inc. (NASDAQ: SPAI) Joins Russell Microcap(R) Index, Signaling Growing Investor Recognition, Market Visibility
Safe Pro Group (NASDAQ: SPAI), an emerging provider of AI-powered security and threat detection solutions, announced its addition to the Russell Microcap(R) Index, effective after market close on June 27, 2025. The inclusion comes as…
-
MissionIRNewsBreaks – BluSky AI Inc. (OTC: BSAI) Secures 9.3 MW Power and Land for Flagship Utah Data Center
BluSky AI (OTC: BSAI), a developer of modular AI data center infrastructure, announced the acquisition of its first operational site in Central, Utah, securing 9.3 MW of grid-connected power through an agreement with Digital Asset…
-
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Subsidiary to Acquire 49% Stake in Prominent Florida Neuropsychiatry Clinic
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, and its wholly-owned subsidiary HOPE Therapeutics, Inc., a multi-site clinical care delivery organization, recently signed a binding letter of intent to acquire a 49% stake in Cohen…
-
Clene Inc. (NASDAQ: CLNN) to Conduct Neurofilament Biomarker Analysis for CNM-Au8(R) in ALS in Early Q4 2025
Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple…
-
BlueSky AI Inc. (BSAI) Expands Market Presence with Strategic Milestones in AI Infrastructure
BlueSky AI (OTC: BSAI) has rapidly emerged as a key player in modular AI data center infrastructure, achieving major milestones in the past two years. The company has moved from concept to execution with its scalable…
-
Nutriband Inc. (NASDAQ: NTRB) Added to Four Key Indexes, Rethinking Opioid Safety in a Time of Crisis
The opioid crisis remains one of the most pressing public health challenges of our time. While synthetic opioids like fentanyl play a crucial role in managing severe pain, their high abuse potential has led to…
-
SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Continues to Target Data Center Boom with Renewable Energy Focus Amid Soaring AI Power Demands
Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), a premier developer and owner of renewable and clean energy projects, specializing in distributed and community solar initiatives throughout Canada and…
-
MissionIRNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Expands Performance-Driven Portfolio with ‘Fast Motion’
Newton Golf Company (NASDAQ: NWTG) is positioned for opportunity as it brings innovation to golf players seeking performance gains. The company recently launched its latest product: the Fast Motion shaft family, aiming to redefine performance standards…
-
MissionIRNewsBreaks – FAVO Capital Inc. (FAVO) Poised in New Era for Tech-Enabled SMB Lending
As the private credit market continues to evolve, FAVO Capital (OTC: FAVO) is positioned to capitalize on emerging opportunities. “FAVO stands out as a leading private credit provider, specializing in delivering fast, efficient and personalized funding solutions…
-
MissionIRNewsBreaks – Why Solowin Holdings (NASDAQ: SWIN) Is ‘One to Watch’
Solowin Holdings (NASDAQ: SWIN) is focused on delivering comprehensive investment solutions from traditional finance as well as decentralized finance to high-net-worth and institutional clients. “Operating through its wholly owned subsidiary, Solomon JFZ (Asia) Holdings Limited, Solowin…
-
Soligenix Inc. (NASDAQ: SNGX) Highlights Encouraging Phase 3 Progress for HyBryte(TM) in Investment Webinar
In a recent webinar hosted by Allele Capital, Soligenix (NASDAQ: SNGX) executives Dr. Christopher Schaber and Dr. Christopher Pullion shared detailed updates on the company’s HyBryte(TM) (synthetic hypericin) clinical development (https://ibn.fm/dz7eO). The event offered an in-depth look…
-
MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Added to Four Russell Indexes in 2025 Reconstitution
Nutriband (NASDAQ: NTRB) has been added to the Russell Microcap, Russell Microcap Growth, Russell 3000E, and Russell 3000E Growth Indexes as part of the 2025 Russell indexes reconstitution. CEO Gareth Sheridan called the inclusion a…
-
MissionIRNewsBreaks – Eloro Resources Ltd. (TSX.V: ELO) (OTCQX: ELRRF) (FSE: P2QM) Amends Payment Schedule for Iska Iska Interest, Updates Adjacent Property Agreement
Eloro Resources (TSX: ELO) (OTCQX: ELRRF) (FSE: P2QM) has reached a mutual agreement with Empresa Minera Villegas S.R.L. to amend the payment terms for acquiring 100% interest in the Iska Iska silver-tin polymetallic project in…
-
MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Advancing Novel Immunotherapy to Combat Antibiotic Resistance
Soligenix (NASDAQ: SNGX) is at the forefront of the effort as the medical community urgently seeks alternative treatments for bacterial infections in the face of escalating antibiotic resistance. The company’s SGX943 therapy “is based on dusquetide,…
-
MissionIRNewsBreaks – Why Lantern Pharma Inc. (NASDAQ: LTRN) Is ‘One to Watch’
Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company, is leveraging artificial intelligence and machine learning to redefine oncology drug development. Through its proprietary platform, RADR(R) (Response Algorithm for Drug Positioning & Rescue), Lantern is advancing…
-
MissionIRNewsBreaks – Clene Inc. (NASDAQ: CLNN) Advances Regulatory Strategy for CNM-Au8 with FDA Meetings Scheduled for ALS and MS Programs
Clene (NASDAQ: CLNN) announced key regulatory developments following a Type C meeting with the FDA, where it received feedback on its statistical analysis plan (SAP) for evaluating neurofilament light (NfL) biomarker data from its Expanded Access…
-
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Applies for FDA Commissioner’s National Priority Voucher for IV Ketamine NRX-100
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company developing innovative treatments for suicidal depression and PTSD, is accelerating its push toward regulatory approval of NRX-100, a preservative-free intravenous ketamine formulation. The company has filed an…
-
Lantern Pharma Inc.’s (NASDAQ: LTRN) AI-Powered Platform Delivers Promising and Durable Results in Lung Cancer Trial
Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company leveraging artificial intelligence and machine learning to redefine oncology drug development, recently reported an encouraging clinical outcome in its Phase 2 HARMONIC(TM) trial, where a patient with…
-
MissionIRNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Highlights PC111 Breakthrough After Scientist Wins Top Italian Dermatology Award
Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharma company focused on inflammation and immunology, announced that Dr. Roberta Lotti of Pincell Srl has won the “Oscar of Italian Dermatology” from SIDeMaST for her research on PC111, a…
-
MissionIRNewsBreaks – FAVO Capital Inc. (FAVO) Eyes Opportunity at Crossroads of Fintech Innovation, Lending Demand
As traditional banks retreat from Main Street, alternative lenders are stepping up to fill the gap, reshaping the $1.7 trillion small business lending market. With policymakers calling for renewed focus on small business financing and…
-
MissionIRNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Expands Fingerprint Drug Testing Across Scandinavia with Spjotgard Partnership
Intelligent Bio Solutions (NASDAQ: INBS), a medical technology firm specializing in non-invasive drug screening, reported continued success in its partnership with Spjotgard, a Scandinavian distributor. The collaboration is accelerating adoption of INBS’ fingerprint-based Drug Screening…
-
D-Wave Quantum Inc. (NYSE: QBTS) Partners with Yonsei University and Incheon City to Advance Quantum Adoption in South Korea
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, has entered into a strategic partnership with Yonsei University and Incheon Metropolitan City designed to accelerate quantum computing adoption and…
Search Articles
Latest Articles
- MissionIRNewsBreaks – AI-Driven Energy Demands Highlight Strategic Value of Platinum Group Metals Ltd.’s (NYSE American: PLG) (TSX: PTM) Waterberg Project
- Brera Holdings PLC’s (NASDAQ: BREA) Becomes Second Multi-Club Owner in Italy’s Serie B, Signaling Rising Investment Opportunity
- MissionIRNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics(TM) Secures Florida Regulatory Clearance to Close Dura Medical Acquisition
- MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Secures FDA Type C Meeting for AVERSA(TM) Fentanyl Abuse-Deterrent Patch
- MissionIRNewsBreaks – Silvercorp Metals Inc. (TSX: SVM) (NYSE American: SVM) Reports Q1 Fiscal 2026 Net Income of $18.1 Million on $81.3 Million Revenue